Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 603, Pages eabf3637
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-07-22
DOI
10.1126/scitranslmed.abf3637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse
- (2021) A. B. Sanchez-Spitman et al. Scientific Reports
- A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping
- (2020) David Twesigomwe et al. npj Genomic Medicine
- Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics
- (2020) Ondřej Slanař et al. Expert Opinion on Drug Metabolism & Toxicology
- Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study
- (2019) Anabel Sanchez-Spitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Determinants of CYP2D6 mRNA levels in healthy human liver tissue
- (2019) Miaoran Ning et al. CTS-Clinical and Translational Science
- Functional and structural characterisation of common cytochrome P450 2D6 allelic variants—roles of Pro34 and Thr107 in catalysis and inhibition
- (2019) Amelia Nathania Dong et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Machine Learning in Medicine
- (2019) Alvin Rajkomar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen
- (2019) A.B. Sanchez-Spitman et al. Expert Review of Clinical Pharmacology
- Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
- (2019) Zahra Khalaj et al. Frontiers in Pharmacology
- Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths
- (2019) M. Martinez-Matilla et al. Forensic Science International-Genetics
- Pharmacogenomics
- (2019) Dan M Roden et al. LANCET
- Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
- (2019) Sisi Qin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
- (2019) Kelly E. Caudle et al. CTS-Clinical and Translational Science
- Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
- (2018) Patrick Neven et al. CLINICAL CANCER RESEARCH
- Genetic polymorphisms of 3′-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy
- (2018) A. B. Sanchez-Spitman et al. BREAST CANCER RESEARCH AND TREATMENT
- Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation
- (2018) Takahiro Saito et al. Drug Metabolism and Pharmacokinetics
- A primer on deep learning in genomics
- (2018) James Zou et al. NATURE GENETICS
- CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele)
- (2018) Balmiki Ray et al. Pharmacogenetics and Genomics
- Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
- (2017) A. B. Sanchez Spitman et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing
- (2017) Henk P.J. Buermans et al. HUMAN MUTATION
- The effect of rs5758550 on CYP2D6*2 phenotype and formation of endoxifen in breast cancer patients using tamoxifen
- (2017) Anabel B Sanchez-Spitman et al. PHARMACOGENOMICS
- Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
- (2017) Werner Schroth et al. Frontiers in Pharmacology
- Pronounced Interindividual But Not Intraindividual Variation in Tamoxifen and Metabolite Levels in Plasma During Adjuvant Treatment of Women With Early Breast Cancer
- (2016) Alan K. Fotoohi et al. THERAPEUTIC DRUG MONITORING
- CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
- (2015) V. O. Dezentjé et al. BREAST CANCER RESEARCH AND TREATMENT
- In vivoassessment of the metabolic activity of CYP2D6 diplotypes and alleles
- (2015) Daniel L. Hertz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Addressing phenoconversion: the Achilles' heel of personalized medicine
- (2015) Rashmi R. Shah et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Heritability of metoprolol and torsemide pharmacokinetics
- (2015) J Matthaei et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine
- (2015) Zhi-Xu He et al. DRUG METABOLISM REVIEWS
- Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6
- (2015) Wanqiong Qiao et al. HUMAN MUTATION
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
- (2014) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
- (2014) J. Hicks et al. CURRENT DRUG METABOLISM
- Functional Characterization of Wild-type and 49 CYP2D6 Allelic Variants for N-Desmethyltamoxifen 4-Hydroxylation Activity
- (2014) Yuka Muroi et al. Drug Metabolism and Pharmacokinetics
- Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity
- (2013) Danxin Wang et al. HUMAN MOLECULAR GENETICS
- Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms
- (2013) Janine E. Micheli et al. Pharmacogenetics and Genomics
- PharmGKB summary
- (2013) Katrin Sangkuhl et al. Pharmacogenetics and Genomics
- Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
- (2013) Kathrin Klein et al. Frontiers in Genetics
- Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients
- (2011) Kazuma Kiyotani et al. BREAST CANCER RESEARCH AND TREATMENT
- Pharmacogenomics of Tamoxifen Therapy
- (2009) H. Brauch et al. CLINICAL CHEMISTRY
- Cytochrome P450 2D6
- (2009) Ryan P. Owen et al. Pharmacogenetics and Genomics
- Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)
- (2008) K. Sakuyama et al. DRUG METABOLISM AND DISPOSITION
- The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements
- (2008) Andrea Gaedigk et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now